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Abstract
Purpose Definitive fascial closure is an essential treatment objective after open abdomen treatment and mitigates morbidity 
and mortality. There is a paucity of evidence on factors that promote or prevent definitive fascial closure.
Methods A multi-center multivariable analysis of data from the Open Abdomen Route of the European Hernia Society 
included all cases between 1 May 2015 and 31 December 2019. Different treatment elements, i.e. the use of a visceral protec-
tive layer, negative-pressure wound therapy and dynamic closure techniques, as well as patient characteristics were included 
in the multivariable analysis. The study was registered in the International Clinical Trials Registry Platform via the German 
Registry for Clinical Trials (DRK00021719).
Results Data were included from 630 patients from eleven surgical departments in six European countries. Indications for 
OAT were peritonitis (46%), abdominal compartment syndrome (20.5%), burst abdomen (11.3%), abdominal trauma (9%), 
and other conditions (13.2%). The overall definitive fascial closure rate was 57.5% in the intention-to-treat analysis and 71% 
in the per-protocol analysis. The multivariable analysis showed a positive correlation of negative-pressure wound therapy 
(odds ratio: 2.496, p < 0.001) and dynamic closure techniques (odds ratio: 2.687, p < 0.001) with fascial closure and a nega-
tive correlation of intra-abdominal contamination (odds ratio: 0.630, p = 0.029) and the number of surgical procedures before 
OAT (odds ratio: 0.740, p = 0.005) with DFC.
Conclusion The clinical course and prognosis of open abdomen treatment can significantly be improved by the use of 
treatment elements such as negative-pressure wound therapy and dynamic closure techniques, which are associated with 
definitive fascial closure.
Keywords Open abdomen · Peritonitis · Fascial closure · Hernia · Abdominal compartment syndrome · Abdominal trauma · 
Burst abdomen · NPWT · VAC
Introduction
Open abdomen treatment (OAT) involves the deliberate 
decision not to close the fascia at the end of laparotomy 
[1, 2]. This surgical strategy is used in the management of 
critically ill patients with serious intra-abdominal conditions 
[3–5], e.g. severe secondary peritonitis, abdominal trauma, 
or abdominal compartment syndrome.
Since its introduction, OAT has become an established 
treatment strategy [1, 6, 7]. Its objectives are to reduce 
the extent of initial surgery as part of a damage control or 
The memberes of the EURAHS Open Abdomen Group are 
mentioned in "Acknoledgements" section.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s1002 9-020-02336 -x) contains 
supplementary material, which is available to authorized users.
 * J. F. Lock 
 Lock_J@ukw.de
Extended author information available on the last page of the article
 Hernia
1 3
abbreviated laparotomy strategy, to temporarily close the abdo-
men in a sterile environment and tension-free environment, 
and to facilitate second-look operations. Morbidity and mor-
tality rates can thus be reduced in critically ill patients whose 
systemic compensatory mechanisms are depleted and whose 
physiological reserves are nearly exhausted [3–6, 8].
OAT serves as a preventive and therapeutic measure in the 
septic abdomen, in damage control situations and when the 
abdominal compartment syndrome (ACS) has developed. The 
main objective once the abdominal situation is under control 
is to achieve definitive fascial closure (DFC) (i.e. definitive 
fascial closure) as soon as possible to decrease secondary mor-
bidity since early DFC is associated with lower mortality and 
complication rates [9–11].
Treatment without fascial closure has severe consequences 
not only during but also after a hospital stay. Giant planned 
ventral hernias are an inevitable result and require complex 
secondary reconstructive procedures, which are also associ-
ated with considerable risks [12–14]. Quality of life, which is 
an important parameter for assessing the condition of patients 
after a hospital stay, is severely reduced in patients with giant 
ventral hernias [15, 16].
The combination of different OAT elements such as vac-
uum-assisted wound closure and mesh-mediated fascial trac-
tion (VAWCM), negative-pressure wound therapy (NPWT) 
and dynamic fascial sutures (DFS) is associated with the 
highest frequency of DFC [11, 16–19]. The purpose is to cre-
ate synergistic effects of edema reduction and gradual fascial 
approximation [18, 20–22].
OAT with VAWCM represents the current gold standard 
with fascial closure rates of up to 90% and is acknowledged 
to be superior to other techniques without mechanical fascial 
traction, which provide maximum fascial closure rates of up 
to 60% [3, 9, 21, 23–26]. For this reason, the current European 
Hernia Society (EHS) guidelines already recommend the use 
of dynamic closure techniques (DCTs) but point out that the 
level of evidence is low [27].
Research work has not yet systematically addressed and 
analyzed the role of different potentially crucial patient and 
surgical factors. The focus of previous studies has so far been 
on comparing different techniques that comprise several dif-
ferent factors. A further question is whether the various treat-
ment factors play the same role regardless of the underlying 
indication for OAT.
We therefore chose this multi-center registry approach to 
investigate what patient-related and which surgical technical 
factors have an impact on DFC in OAT.
Material and methods
Registry
Since 1 May 2015, every hospital can enter data online 
into the Open Abdomen Route, which is a registry of the 
European Hernia Society (EHS) that was established as 
a module of the European Registry of Abdominal Wall 
Hernias (EuraHS  – www.eurah s.eu). In cooperation 
with the EHS, the registry was implemented by a work-
ing group of surgeons from the Department of General, 
Visceral, Transplantation, Vascular and Pediatric Surgery 
at the University Hospital of Würzburg and the Depart-
ment of General, Visceral and Thoracic Surgery at the 
Federal Armed Forces Central Hospital in Koblenz. The 
EuraHS IT platform was developed by the Department 
of Artificial Intelligence and Applied Informatics of the 
Institute for Mathematics and Computer Science at the 
University of Würzburg in Germany [28]. EuraHS was 
established in 2012 and currently provides six different 
registries (routes). The Open Abdomen Route was cre-
ated to allow data to be collected and analyzed from open 
abdomen patients from multiple centers in a systematic 
and standardized manner and thus to achieve a higher level 
of evidence [29].
The Open Abdomen Route covers 110 variables on 
every patient and course of treatment and is divided into 
11 categories that provide information on the treating hos-
pital, the patient, underlying conditions and comorbidi-
ties, open abdomen management, clinical course, and three 
clinical follow-up assessments (Supplement 1).
Data collection
All data are pseudonymized so that only the responsible 
hospital can re-identify patients. A case-related iden-
tification number is assigned to every patient during 
registration.
The study was approved by the ethics commission of the 
State of Rhineland-Palatinate, Germany [No.: 837 534 13 
(9219-F) as well as in the ethical review boards of the hos-
pitals entering data. Data entry requires previous written 
informed consent from the patient or a legal representative. 
Additionally, the study was registered in the International 
Clinical Trials Registry Platform via the German Regis-
try for Clinical Trials (DRK00021719). The EuraHS data 
protection regulations and publication guidelines must be 
observed [28]. The Open Abdomen Route is supported 
by an advisory panel from CAMIN (Surgical Working 
Group for Military and Emergency Surgery), which is a 
working group of the DGAV (German Society for General 
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and Visceral Surgery). For the present analysis, a separate 
Open Abdomen Study Group was formed within the Open 
Abdomen Route. All members gave their consent for par-




All cases entered into the registry between 1 May 2015 and 
31 December 2019 were included in the present analysis.
Participating hospitals
The patients whose data were analyzed here underwent treat-
ment at hospitals that are members of the Open Abdomen 
Study Group, which was formed within the Open Abdomen 
Route (www.eurah s.eu). Data were provided by eleven hos-
pitals (Supplement 2).
Inclusion criteria
• All OAT patients.
• All indications and underlying diseases.
• All types of OAT-related surgical techniques.
• Minimum survival > 24 h after initiation of OAT (index 
procedure).
• Informed consent (patient or legal representative).
Exclusion criteria
• No informed consent.
• Death within 24 h after the initiation of open abdomen 
management.
• Data set for the variables included in the analysis was 
incomplete.
• Death before termination of OAT led to exclusion from 
the analysis of DFC (endpoint) (per-protocol analysis).
Definitions
Study endpoint: definitive fascial closure (DFC) after com-
pletion of OAT in a per-protocol analysis.
According to the EHS, DFC is any situation where the 
fascia is completely closed, i.e. the fascial edges are com-
pletely sutured together with no remaining fascial defect 
(fascia-to-fascia closure) [27]. DFC was not achieved if 
a fascial gap was present, regardless of whether alloplas-
tic mesh had been used to bridge the defect or augment or 
replace the fascia.
Patients who died before the completion of OAT were 
excluded from the multivariate analysis of DFC.
The group of patients in which the study endpoint 
DFC was not achieved thus comprised all cases in which 
abdominal closure had been achieved using one of the fol-
lowing techniques:
• Closure of skin and subcutaneous tissue only (planned 
ventral hernia)
• Granulation of the abdominal wall defect and subsequent 
coverage of the defect with a split-thickness skin graft
• Granulation tissue formation through Vicryl® (polyg-
lactin 910) mesh, which was placed in inlay position to 
bridge the defect, and subsequent coverage with a split-
thickness skin graft
• All uses of alloplastic mesh (intraperitoneal onlay mesh, 
inlay, onlay, sublay) in which a fascial defect was bridged 
and complete fascial closure was not achieved
Open abdomen treatment (OAT) elements
The different types of open abdomen treatment elements and 
techniques were investigated on the basis of three aspects:
• Management of the fascia
• Management of the viscera
• Application of negative-pressure wound therapy
Dynamic closure techniques (DCT)
DCT comprises all techniques that use dynamic procedures 
to gradually and actively reduce the fascial defect. Used 
techniques were mesh-mediated fascial traction and dynamic 
fascial sutures. Simple mesh interposition without gradual 
reduction of the fascial defect was not considered a DCT.
Visceral protective layer (VPL)
VPL includes all techniques that involve the intra-abdominal 
placement of an inert non-adhesive protective layer as deep 
as possible into the paracolic gutters, the retropubic space 
and the subxiphoidal region as this was shown to reduce 
enteroatmospheric fistula (EAF) formation [30].
Negative‑pressure wound therapy (NPWT)
NPWT includes all techniques in which negative pressure or 
suction is actively applied to remove exudate. Drains (Jack-
son–Pratt drains, Robinson drains, etc.) that are used for the 
passive removal of fluids do not meet this requirement.
Classification of the open abdomen
The study is based on Björck’s initial classification that was 
published in 2009 and amended in 2016 [31, 32]. This sys-




Until 2016 we used the definitions for sepsis as proposed 
by Bone et al. in 1992. Since 2016, we have used the Third 
International Consensus definitions as published by Singer 
et al. [33, 34].
Abdominal compartment syndrome (ACS)
ACS was defined as a sustained intra-abdominal pressure 
(IAP) increase above 20 mmHg with at least one new-onset 
organ dysfunction or, alternatively, an abdominal perfusion 
pressure (APP) above 60 mmHg with at least one new-onset 
organ failure [35].
Statistical analysis
Data was analyzed using descriptive statistical methods. 
Metric variables were tested for normal distribution using 
the Kolmogorov–Smirnov test. Normally distributed vari-
ables were presented as means ± standard deviations. Non-
normally distributed variables were presented as medians 
and 95% confidence intervals (CIs). Depending on the dis-
tribution and the level of measurement, univariate analyses 
were performed using Fisher’s exact test, the chi-squared 
test or the Mann–Whitney U test. The significance threshold 
was set at p = 0.05.
We performed a multivariate logistic regression analysis 
to identify possible factors that influence the target variable. 
DFC yes/no was defined as the dependent variable (target 
variable) and potential influencing factors were defined as 
independent variables. The constellation of variables in 
the regression model was formed by means of the inclu-
sion method, i.e. all selected independent variables were 
included, and a forward stepwise analysis was performed 
(likelihood ratio). Furthermore, a subgroup analysis for the 
two largest subgroups “peritonitis” and “ACS” was per-
formed to address the question of whether the various treat-
ment factors play the same role in different OAT indications.
We calculated the coefficient of determination (Nagel-
kerke’s pseudo R2), the odds ratio to evaluate the regression 
model and effect size.
Data were processed and analyzed using Excel (2010, 
Microsoft, Redmond, United States), XLSTAT (Addinsoft, 
Paris, France), and SPSS (version 25, IBM, Armonk, United 
States).
Results
From 1 May 2015 to 31 December 2019, 679 data sets that 
had been provided by the Open Abdomen Study Group were 
retrieved from the Open Abdomen Route via www.eurah 
s.eu. Of these, 630 data sets offered complete information on 
the variables investigated in this study and were provided by 
eleven hospitals which provide tertiary or advanced second-
ary care in six European countries.
In accordance with the study protocol, patients who died 
before the completion of OAT were excluded from the mul-
tivariable analysis, which examined the effects of a variety 
of factors on DFC. The analysis thus included 510 survivors 
in the per-protocol analysis (Fig. 1).
Demographic data
The mean age of the patients was 59.8 ± 15.9 years. Two 
thirds of them were male. The mean body mass index (BMI) 
was 28.7 at the initiation of OAT. Table 1 provides an 
Fig. 1  Prism flow chart of patient inclusion
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overview of data and comorbidities of the patients included 
in this study.
Overall hospital mortality was 19% (120 of 630 patients). 
Table 1 provides an overview of the epidemiology, comor-
bidities and outcome of the patients included in this study.
Indications for the open abdomen
The majority of patients required OAT for peritonitis (46%), 
followed by abdominal compartment syndrome (ACS) 
(20.5%), burst abdomen (11.3%), abdominal trauma (9%), 
surgical bleeding requiring re-operation (5.6%), intestinal 
ischemia (2.5%), and other indications (5.1%) (Fig. 2).
Fascial closure (study endpoint)
The DFC rate was 57.5% (362 of 630 patients) in the inten-
tion-to-treat analysis and 71% (362 of 510 patients) in the 
per-protocol analysis, which excluded patients who had died 
during OAT (Table 2). There were significant differences 
in DFC rates (58–100%) between participating hospitals 
Table 1  Patient and treatment characteristics
OAT open abdomen treatment, OA open abdomen
Patient characteristics
Number of patients 630
Age (years) 59.82 ± 15.9 (median: 61.62)
Gender (female/male) 210 (33.3%)/420 (66.7%)
Body mass index (BMI) 28.7 ± 23.9 (median: 26.12)
Malignancy 141 (22.4%)
Diabetes 91 (14.4%)
Cardiopulmonary disease 253 (40.2%)
Immunosuppression 52 (8.3%)
Mannheim Peritonitis Index (MPI) 21 ± 8 (median: 22)




Length of stay before OAT (days) 9.05 ± 15.26 (median: 4)
OAT after first operation yes/no 305 (48.4%)/325 (51.6%)
Surgical procedures before OAT 1 (n = 202/32%)
2 (n = 81/12.9%)
3 (n = 29/4.6%)
4 (n = 13/2.1%)
Type of incision (midline/transverse/combined) 502 (79.7%)/56 (8.9%)/12 (1.9%)
Indication for previous surgery (elective/emergency) 198 (31.4%)/419 (66.5%)
Intra-abdominal contamination at the initiation of OAT (yes/no) 290 (46%)/340 (54%)
Sepsis at the initiation of OAT (yes/no) 228 (36.2%)/402 (63.8%)
Björck’s classification at the initiation of OAT Grade 1A—clean OA (27.9%)
Grade 1B—contaminated OA (21.4%)
Grade 2A—clean OA developing adherence (12.0%)
Grade 2B—contaminated OA developing adherence (33.1%)
Grade 3—OA complicated by fistula (2.6%)
Grade 4—frozen OA (2.9%)
Björck’s classification at the completion of OAT Grade 1A—clean OA (26.5%)
Grade 1B—contaminated OA (1.5%)
Grade 2A—clean OA with adherence (51.4%)
Grade 2B—contaminated OA with adherence (2.9%)
Grade 3—fistula (9.7%)
Grade 4—frozen abdomen (5.8%)
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(p < 0.001), which, however, did not depend on OAT indi-
cations (Table 3).
There were 42 patients with a mesh at the end of OAT. 
17 (40.5%) as a prophylactic mesh with a definitive fascial 
closure, 25 (59.5%) without a definitive fascial closure as a 
fascial bridging technique.
The role of fascial closure
Successful DFC did not significantly reduce hospital length 
of stay (LOS) after OAT completion but was associated 
with a significant decrease in mortality from 23% (34 of 
148 patients) to 14.1% (51 of 311 patients) (p = 0.015). In 
addition, the group of patients with DFC showed a signifi-
cantly lower incidence of enteroatmospheric fistula (5.5% 
vs. 17.6%) (p < 0.001).
Treatment course data for the entire patient 
population
Treatment before open abdomen treatment
A detailed overview of treatment characteristics is provided 
in Table 1.
Open abdomen treatment
In only 30.3% of the cases was OAT performed according to 
an established standard treatment protocol. In all other cases, 
the individual surgeon responsible for the patient decided 
how to manage the patient. The mean duration of OAT was 
16.1 ± 24.9 days. During this period, a mean number of 
3.9 ± 3.7 procedures were performed.
Thirteen different open abdomen techniques were used 
in the management of the patient population studied here 
(Fig. 3). They are investigated according to the three prede-
fined elements of treatment groups (Fig. 4).
Factors influencing DFC
A univariate analysis showed that polytrauma was associ-
ated with a significantly higher fascial closure rate than 
other indications for OAT (87.5% versus 69.9%, p = 0.033) 
whereas the presence of intra-abdominal contamination 
resulted in a significantly lower fascial closure rate than 
the absence of intra-abdominal contamination (66.2% 
versus 75.1%, p = 0.028). Likewise, higher-grading of 
the OA, based on Björck’s classification system, both at 
the initiation and at the completion of OAT, showed sig-
nificantly lower fascial closure rates. Longer duration of 
OAT adversely affected fascial closure (Table 2). All three 
Fig. 2  Indications for the open abdomen (number of patients)
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treatment elements (NPWT, DCT, VPL) were positively 
correlated with achieving fascial closure (Table 2). In par-
ticular, a combination of NPWT, DCT and VPL achieved 
the best overall results with the highest fascial closure rate 
compared to all other techniques not using this combina-
tion (85.8% vs. 61.1) (Table 2).
74.3% of the vacuum therapies were carried out using 
commercial systems, 16.9% using wall suction and 1.1% 
using other systems. There was no difference in the rate 
of fascial closure between the various manufacturers of 
the commercial systems. However, there was a significant 
difference between the commercial and improvised 
vacuum systems with wall suction (82.8% vs. 58.1%, 
p < 0.001).
The results of the multivariable logistic regression are 
shown in Table 3. In the last step of the regression, the 
use of NPWT and the use of DCT were independently 
correlated with the study endpoint DFC (Table 3). Intra-
abdominal contamination and the number of surgical pro-
cedures before OAT initiation were negatively correlated 
with DFC (Table 3).
Table 2  Fascial closure and univariate analysis of influencing factors
OAT open abdomen treatment, VPL visceral protective layer, NPWT negative-pressure wound therapy, DCT dynamic closure techniques
Percentage of patients Number of patients p value
Complete fascial closure (per-protocol analysis) 71 (362/510)
Complete fascial closure (intention-to-treat analysis) 57.5 (362/630)
Range of fascial closure rates across hospital departments 58–100 (80/138–21/21)  < 0.001
Fascial closure rates according to OA indication 0.215
 Trauma 80.9 (38/47)
 Peritonitis 66.2 (157/237)
 Abdominal compartment syndrome 76.8 (73/95)
 Burst abdomen 69 (40/58)
 Surgical bleeding 72.7 (24/33)
 Intestinal ischemia 90 (09/10)
 Other 70 (21/30)
 Polytrauma (yes/no) 87.5 vs. 69,9 (28/32 vs. 334/478) 0.033
 Intra-abdominal contamination (yes/no) 66.2 vs. 75.1 (157/237 vs. 205/273) 0.028
Björck’s classification at the initiation of OAT  < 0.001
 Grade IA 84.2 (80/95)
 Grade IB 90.4 (66/73)
 Grade IIA 75.6 (31/41)
 Grade IIB 66.4 (75/113)
 Grade III 55.6 (5/9)
 Grade IV 50 (5/10)
Björck’s classification at the completion of OAT  < 0.001
 Grade IA 87.6 (127/145)
 Grade IB 93.3 (14/15)
 Grade IIA 69.8 (81/116)
 Grade IIB 77.8 (7/9)
 Grade III 30 (3/10)
 Grade IV 60.4 (9/14)
Duration of OAT  < 0.001
 Short (1–2 reoperations + OAT < 1 week) 77 (194/252)
 Medium (3–6 reoperations + OAT 7–21 days) 81 (77/95)
 Long (7 or more reoperations + OAT > 21 days) 55.9 (90/161)
 VPL (yes/no) 79.1 vs. 57.5 (250/316 vs. 111/193)  < 0.001
 NPWT (yes/no) 78.6 vs. 51.4 (287/365 vs. 74/144)  < 0.001
 DCT (no/yes) 84.8 vs. 60.8 (184/217 vs. 175/288)  < 0.001
 OAT with VPL + NPWT + DCT 85.8 vs. 61.1 (175/204 vs. 187/306)  < 0.001
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In a subgroup analysis, similar results were obtained for 
patients with peritonitis. NPWT and DCT were again asso-
ciated with a higher probability of fascial closure, whereas 
the number of surgical procedures before OAT initiation 
was negatively correlated with DFC (Table 3).
In an analysis of the group of patients with ACS, 
which was the second largest patient group, only the use 
of NPWT was found to be significantly associated with 
successful DFC (Table 3).
Discussion
The present study implements a systematic analysis of a 
multi-centric patient cohort with OAT concerning success-
ful DFC as a key objective to achieve low mortality and 
morbidity. The main findings of this study emphasize the 
importance of a structured treatment plan and technical 
aspects to achieve high DFC rates.
Table 3  Results of the multivariate logistic regression analysis





Standard error Wald df Sig Exp(B) 95% CI for EXP(B)
Lower limit Upper limit
All patients (N = 510)
 Intra-abdominal contamination 0.462 0.212 4.746 1 0.029 0.63 0.415 0.955
 Surgical procedures before OAT initiation 0.302 0.106 8.022 1 0.005 0.74 0.6 0.911
 NPWT − 0.915 0.24 14.561 1  < 0.001 2.496 1.56 3.993
 DCT − 0.988 0.252 15.437 1  < 0.001 2.687 1.641 4.4
Only patients with peritonitis (n = 237)
 Surgical procedures before OAT initiation 0.434 0.162 7.161 1 0.007 0.648 0.471 0.89
 NPWT − 1.311 0.351 13.932 1  < 0.001 3.71 1.864 7.384
 DCT − 0.819 0.366 5.005 1 0.025 2.269 1.107 4.65
Only patients with ACS (n = 129)
 NPWT − 2.293 0.64 12.831 1  < 0.001 9.9 2.824 34.706
Fig. 3  Open abdomen techniques (number of patients). VAWCM vacuum-assisted wound closure and mesh-mediated fascial traction, VAC vac-
uum-assisted closure, NPWT negative-pressure wound therapy, VPL visceral protective layer, DFS dynamic fascial sutures
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Our data emphasize the role of DFC in the course of 
disease during the hospital stay and show that successful 
DFC is associated with lower mortality. A similar rela-
tionship was reported by von Websky et al. in a single-
center study that, unlike the present study, analyzed overall 
mortality over the entire course of treatment [10]. Review 
studies comparing different techniques often demonstrate 
a positive correlation between DFC and survival [9, 25]. 
Moreover, this study confirms the results reported by Cris-
taudo et al. that showed that DFC also reduced the inci-
dence of EAF [9, 25].
The composition of the patient population and the indi-
cations for OA management reflect those commonly found 
in similar cohort of patients in Europe: the most frequently 
reported indication for OA was peritonitis, followed by ACS, 
and burst abdomen. Trauma accounted for only 9% [4, 10, 
11, 17, 36, 37]. In this study, an in-hospital mortality rate of 
19% was in line with the literature on OAT, where it varies 
between 10 and 45% [14, 23, 36–41]. The fact that 36% of 
the patients in this study met the applicable criteria for sepsis 
at the initiation of OA underlines the fact that most of these 
patients were critically ill [33, 34].
A novel methodological aspect in this investigation is the 
identification and analysis of the independent roles of indi-
vidual technical and patient-related factors and the summa-
tion of several surgical strategies into “three key elements” 
in OAT.
Some of these factors were already examined in former 
studies in single factorial analyses. Especially the impact of 
NPWT during OAT was shown concerning several treat-
ment aspects [42, 43]. Despite many advantages, NPWT 
alone may not be able to sufficiently prevent fascial later-
alization during OAT especially in patients with peritoni-
tis and patients requiring long treatment courses [44]. As 
a result, mean fascial closure rates of 60% are reported in 
per-protocol analyses and only approximately 30% in some 
patient populations [25, 45, 46].
In a large multi-centric study by Carlson, vacuum therapy 
alone was even inferior to a mixed patient cohort treated 
with other techniques with and without DCT with regard 
to DFC [37].
In 2017, Acosta et al. found in a review article including 
eleven observational studies that high fascial closure rates 
can be achieved with VAWCM even in elderly non-trauma 
patients, most of whom presented with peritonitis [16]. This 
method was first described in 2007 [39]. This result was 
confirmed by other authors like Cristaudo et al. and Atema 
et al. concerning different types of patient populations. They 
found that a combination of NPWT and DCT was superior 
to NPWT alone with regard to DFC [9]. In their clinical 
guidelines on the management of the abdominal wall in the 
context of the open or burst abdomen, the EHS too recom-
mended the use of DCT and NPWT on the basis of a meta-
analysis but reported that the level of evidence was low [27].




In this study, the highest fascial closure rates were 
obtained for the total patient population when OAT com-
bined the three key treatment elements NPWT, VPL, and 
DCT.
This result applies to both the total patient population 
and the subgroup of patients with peritonitis. By contrast, 
NPWT alone is successful in patients with ACS. The differ-
ent pathophysiologies are a likely explanation for this find-
ing since NPWT is the treatment element to reduce bowel 
edema [42].
Intra-abdominal contamination and the number of surgi-
cal procedures before OAT were found to be the only factors 
that were negatively correlated with DFC. This result con-
firms the previous observation reported by Karhof et al. [4].
Moreover, patient-related factors were not significantly 
associated with DFC in the multivariable analysis. There 
was a difference in DFC rates between the different indica-
tions and we obtained the highest rates for trauma patients 
(more than 80%), as did earlier studies, but the difference 
was not statistically significant [11, 36, 47].
Our findings and recent results from the literature con-
cerning the role of a visceral protective layer (VPL) in the 
prevention of fistulas suggest that an ideal approach to OAT 
consists of a combination of VPL, NPWT and DCT [30]. 
As a result, maximum synergistic effects can be achieved 
through a combination of fascial traction using DCT, edema 
reduction using NPWT, and the prevention of adhesions and 
fistula formation using VPL.
Taken together, available data support a fundamental role 
for technique-related factors that, independently of each 
other, have positive effects on DFC. Both DCT and NPWT 
were found to be independent factors that contribute to suc-
cessful DFC.
The present study furthermore reveals the use of a wide 
diversity of techniques (13 different techniques) and a low 
level of treatment standardization (approximately 30% of the 
cases). The best results, however, have so far been reported 
in those studies that showed the highest level of in-hospital 
standardization [11, 17, 19, 36, 48]. A growing body of evi-
dence from meta-analyses and registry-based studies that 
have been conducted in recent years, however, will probably 
lead to an increase in in-hospital standardization [9, 26, 29, 
49, 50].
Conclusions
The present study is the first systematic multi-center analysis 
of different factors that promote or prevent fascial closure 
after OAT. It found that the three principles DCT, NPWT 
and the use of a VPL resulted in the highest DFC rates. 
Two of the four factors that were found to be significantly 
associated with fascial closure are not patient-related but 
treatment-related factors. These factors can be influenced by 
the surgeon, i.e. NPWT and DCT. An integrative approach 
combining the above principles allows surgeons to actively 
and positively promote the course of OAT and reduce the 
risks and complications potentially associated with it.
Limitations
Basically, there is a strong heterogeneity of the individual 
patient groups in the individual clinics. The classification 
into the treatment elements serves the purpose of improving 
comparability and analysis in this respect. In the absence of 
sufficiently large numbers of patients, a multivariate analy-
sis has not yet been performed with a view to assessing the 
effects of a variety of factors on DFC as a study endpoint. 
For this reason, comparisons with other studies (single-
center observational studies, meta-analyses, etc.) are subject 
to limitations from a methodological perspective.
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